Ingrid Goldberg | Vice President of Investor Relations |
William Doyle | Executive Chairman |
Asaf Danziger | Chief Executive Officer |
Ashley Cordova | Chief Financial Officer |
Pritesh Shah | Chief Growth Officer |
Na Sun | JPMorgan Chase & Co. |
Jason Wittes | Loop Capital |
Lei Huang | Wells Fargo |
Jason Bednar | Piper Sandler |
Greg Fraser | Truist Securities |
Vijay Kumar | Evercore ISI |
Emily Bodnar | H.C. Wainwright |
Good morning, everyone, and thank you for joining us to review Novocure's Fourth Quarter and Full Year 2022 Performance. I'm joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for Q&A.
For your reference, slides accompanying this earnings release can be found on our website, www.Novocure.com, under Quarterly Reports on our Investor Relations page.
Before we start, I would like to remind you that our discussions during this conference call will include forward-looking statements and actual results could differ materially from those projected in these statements.